CD47 Blockade Enhances Therapeutic Activity of TCR Mimic Antibodies to Ultra-Low Density Cancer Epitopes

Clinical Lymphoma, Myeloma and Leukemia - United States
doi 10.1016/j.clml.2016.07.013
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

CD47 Blockade Enhances Therapeutic Activity of TCR Mimic Antibodies to Ultra-Low Density Cancer Epitopes

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2017English

Radiotherapy Enhances Responses of Lung Cancer to CTLA-4 Blockade

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2019English

Mutant MHC Class II Epitopes Drive Therapeutic Immune Responses to Cancer

Nature
Multidisciplinary
2015English

Introduction to Therapeutic Antibodies

Journal of Tumor Medicine & Prevention
2018English

The CD47–SIRPα Pathway in Cancer Immune Evasion and Potential Therapeutic Implications

Current Opinion in Immunology
AllergyImmunology
2012English

Mechanisms of Action of Therapeutic Antibodies for Cancer

Molecular Immunology
ImmunologyMolecular Biology
2015English

CD47-blocking Antibodies Restore Phagocytosis and Prevent Atherosclerosis

Nature
Multidisciplinary
2016English

Masterful Antibodies: Checkpoint Blockade

Cancer immunology research
Cancer ResearchImmunology
2017English

Development of Therapeutic Anti-Jagged1 Antibodies for Cancer Therapy

Molecular Cancer Therapeutics
Cancer ResearchOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy